The DNA-based Lassa vaccine INO-4500 confers durable protective efficacy in cynomolgus macaques against lethal Lassa fever
Viviane M. Andrade(Inovio Pharmaceuticals (United States)), Trevor R.F. Smith(Inovio Pharmaceuticals (United States))
Cited by 10
Related Papers
Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models
|Human Vaccines & Immunotherapeutics|2023|10